US Patent No: 7,368,233

Number of patents in Portfolio can not be more than 2000

Methods of screening for lung neoplasm based on stool samples containing a nucleic acid marker indicative of a neoplasm

Stats

ALSO PUBLISHED AS: 20040043467
ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The invention provides methods and materials for detecting supracolonic aerodigestive premalignant and malignant neoplasms. Specifically, the invention provides methods and materials for determining whether a stool sample from a mammal contains a neoplasm-specific marker from a neoplsm located in the supracolonic aerodigestive tissue of a mammal.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
EXACT SCIENCES CORPORATIONMAYNARD, MA17
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCHROCHESTER, MN624

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ahlquist, David A Rochester, MN 15 59
Shuber, Anthony P Mendon, MA 100 1169

Cited Art

Patent Info (Count) # Cites Year
 
ESOTERIX GENETIC LABORATORIES, LLC (16)
5,670,325 Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample 47 1996
5,830,665 Contiguous genomic sequence scanning 38 1997
5,888,778 High-throughput screening method for identification of genetic mutations or disease-causing microorganisms using segmented primers 51 1997
5,928,870 Methods for the detection of loss of heterozygosity 57 1997
6,100,029 Methods for the detection of chromosomal aberrations 51 1997
6,146,828 Methods for detecting differences in RNA expression levels and uses therefor 51 1998
6,020,137 Methods for the detection of loss of heterozygosity 39 1998
6,143,529 Methods for improving sensitivity and specificity of screening assays 32 1999
6,280,947 Methods for detecting nucleotide insertion or deletion using primer extension 25 1999
6,300,077 Methods for the detection of nucleic acids 22 2000
6,214,558 Methods for the detection of chromosomal aberrations 50 2000
6,503,718 Methods for detecting mutations using primer extension for detecting disease 15 2001
6,428,964 Method for alteration detection 20 2001
6,475,738 Methods for detecting mutations using primer extension for detecting disease 40 2001
6,498,012 Methods for detecting mutations using primer extension for detecting disease 11 2001
6,482,595 Methods for detecting mutations using primer extension 13 2001
 
EXACT SCIENCES CORPORATION (11)
5,741,650 Methods for detecting colon cancer from stool samples 39 1996
5,952,178 Methods for disease diagnosis from stool samples 40 1998
6,268,136 Methods for stool sample preparation 20 1998
6,303,304 Methods for disease diagnosis from stool samples 19 1999
2003/0044,780 PRIMER EXTENSION METHODS UTILIZING DONOR AND ACCEPTOR MOLECULES FOR DETECTING NUCLEIC ACIDS 14 1999
6,551,777 Methods for preserving DNA integrity 16 2000
6,351,857 Stool specimen collector 16 2001
6,406,857 Methods for stool sample preparation 16 2001
2002/0119,469 Methods for the detection of nucleic acids 15 2001
6,415,455 Stool specimen collector 16 2001
2003/0049,659 Devices and methods for isolating samples into subsamples for analysis 26 2002
 
THE JOHNS HOPKINS UNIVERSITY (10)
5,380,645 Generalized method for assessment of colorectal carcinoma 48 1989
5,527,676 Detection of loss of the wild-type P53 gene and kits therefor 91 1993
5,492,808 Means for detecting familial colon cancer (FCC) 42 1993
5,709,998 Molecular diagnosis of familial adenomatous polyposis 38 1993
5,532,108 Gene deleted in colorectal cancer of humans 36 1994
5,580,729 Generalized method for cancer assessment 22 1994
5,910,407 Method for detection of target nucleic acid by analysis of stool 13 1994
5,882,865 Cancer drug screen based on cell cycle uncoupling 9 1997
6,235,474 Methods and kits for diagnosing and determination of the predisposition for diseases 29 1998
6,177,251 Method for detection of target nucleic acid by analysis of stool 21 1999
 
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (4)
5,272,057 Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase 197 1988
5,378,602 Highly informative microsatellite repeat polymorphic DNA markers twenty-[seven]six 47 1991
5,369,004 Five highly informative microsatellite repeat polymorphic DNA markers 47 1992
5,468,610 Three highly informative microsatellite repeat polymorphic DNA markers 56 1993
 
ROCHE MOLECULAR SYSTEMS, INC. (4)
4,683,202 Process for amplifying nucleic acid sequences 2764 1985
4,683,195 Process for amplifying, detecting, and/or-cloning nucleic acid sequences 2436 1986
5,468,613 Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids 72 1990
5,599,662 Oliconucleotide primers and probes for the detection of HIV-1 32 1995
 
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (3)
5,087,617 Methods and compositions for treatment of cancer using oligonucleotides 170 1989
5,248,671 Methods and compositions for treatment of cancer using oligonucleotides 46 1991
5,489,508 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity 119 1993
 
MOSAIC TECHNOLOGIES, INC. (3)
6,251,660 Devices and methods for detecting target molecules in biological samples 46 1998
6,214,187 Denaturing gradient affinity electrophoresis and methods of use thereof 17 1999
6,238,927 Reverse displacement assay for detection of nucleic acid sequences 52 1999
 
AMOCO CORPORATION (2)
5,589,335 Hybridization promotion reagents 22 1994
5,759,777 Hybridization promotion reagents 26 1995
 
BAYLOR COLLEGE OF MEDICINE (2)
5,559,014 Methods and reagents to detect and characterize Norwalk and related viruses 22 1995
5,645,995 Methods for diagnosing an increased risk for breast or ovarian cancer 21 1996
 
HITACHI, LTD. (2)
5,409,586 Method for analyzing nucleic acid or protein and apparatus therefor 32 1993
5,458,761 Method for analyzing nucleic acid or protein and apparatus therefor 55 1995
 
INVITEK GMBH (2)
6,037,465 Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials 31 1996
6,448,002 Method to detect clinically relevant mutations of the DNA sequence of ki-ras oncogene, its use and a testkit for early diagnosis of tumors 10 1999
 
MASSACHUSETTS INSTITUTE OF TECHNOLOGY (2)
4,535,058 Characterization of oncogenes and assays based thereon 72 1982
4,786,718 Method of preparing antibodies to characterize oncogenes 53 1985
 
SIEMENS HEALTHCARE DIAGNOSTICS INC. (2)
5,200,314 Polynucleotide capture assay employing in vitro amplification 63 1990
5,635,352 Solution phase nucleic acid sandwich assays having reduced background noise 70 1995
 
AFFYMETRIX, INC. (1)
5,856,104 Polymorphisms in the glucose-6 phosphate dehydrogenase locus 38 1997
 
AMERICAN HEALTH FOUNDATION (1)
5,512,441 Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method 80 1994
 
BARNES INTERNATIONAL, INC. (1)
5,496,470 Magnetic separator 31 1994
 
BECKMAN INSTRUMENTS, INC. (1)
5,302,509 Method for sequencing polynucleotides 279 1991
 
BOARD OF RIJKS UNIVERSITTEIT LEIDEN THE, WASSENAARSEWEG 72 2333 AL, LEIDEN, THE NETHERLANDS, A PUBLIC BODY OF THE NETHERLANDS (1)
4,871,838 Probes and methods for detecting activated ras oncogenes 61 1985
 
CANCER INSTITUTE, JAPANESE FOUNDATION FOR CANCER RESEARCH (1)
5,352,775 APC gene and nucleic acid probes derived therefrom 54 1991
 
CANCER INSTITUTE, THE A CORPORATION OF JAPAN (1)
5,330,892 MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans 48 1991
 
CARLSON, ERIC V. (1)
5,463,782 Foldable stool sample collection device 34 1994
 
CHILDREN'S MEDICAL CENTER CORPORATION (1)
5,641,628 Non-invasive method for isolation and detection of fetal DNA 45 1994
 
DADE BEHRING INC. (1)
5,506,105 In situ assay of amplified intracellular mRNA targets 22 1994
 
DEKALB GENETICS CORPORATION (1)
5,508,164 Isolation of biological materials using magnetic particles 149 1993
 
DIAGENETICS LTD. (1)
5,710,028 Method of quick screening and identification of specific DNA sequences by single nucleotide primer extension and kits therefor 86 1994
 
E. I. DU PONT DE NEMOURS AND COMPANY (1)
5,126,239 Process for detecting polymorphisms on the basis of nucleotide differences 81 1990
 
FRED HUTCHINSON CANCER RESEARCH CENTER (1)
5,466,576 Modulation of PIF-1-type helicases 44 1993
 
GULL LABORATORIES, INC. (1)
5,612,473 Methods, kits and solutions for preparing sample material for nucleic acid amplification 43 1996
 
HELENA LABORATORIES CORPORATION (1)
5,196,167 Fecal occult blood test product with positive and negative controls 43 1991
 
INSTITIT PASTEUR & CNEVA (1)
5,538,851 Primers for the amplification of genes coding for the enterotoxin and the lecithinase of Clostridium perfringens and their application to the determination of the presence and numeration of these bacteriae 16 1993
 
LABORATORY CORPORATION OF AMERICA HOLDINGS (1)
5,846,710 Method for the detection of genetic diseases and gene sequence variations by single nucleotide primer extension 106 1993
 
LIFECODES CORPORATION (1)
5,514,547 Molecular genetic identification using probes that recognize polymorphic loci 30 1994
 
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (1)
6,084,091 Process for purifying, stabilising or isolating nucleic acids from biological materials 25 1998
 
MILES INC. (1)
5,348,855 Assay for nucleic acid sequences in an unpurified sample 132 1991
 
MONTEFIORE MEDICAL CENTER (1)
4,981,783 Method for detecting pathological conditions 180 1986
 
NATIONAL RESEARCH COUNCIL OF CANADA (1)
5,916,744 Testing for infestation of rapeseed and other cruciferae by the fungus Leptosphaeria maculans (blackleg infestation) 10 1995
 
ONCOSELL, INC. (1)
4,857,300 Cytological and histological fixative formulation and methods for using same 45 1987
 
PHARMAGENICS, INC. (1)
5,362,623 Sequence specific DNA binding by p53 55 1992
 
PRINCETON UNIVERSITY (1)
5,382,510 Methods of diagnosing pre-cancer or cancer states using probes for detecting mutant p53 51 1992
 
PROCYON BIOPHARMA INC. (1)
5,416,025 Screening test for early detection of colorectal cancer 24 1994
 
ROCHE DIAGNOSTICS GMBH (1)
6,150,100 Method for the detection of microsatellite instability for tumor diagnostics 17 1998
 
SAIDI; FARROKH (1)
5,380,647 Simple test for detecting carcinoembryonic antigen in stool 29 1993
 
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (1)
4,333,734 Diagnostic device for fecal occult blood and method of use 56 1980
 
SYNGENE, INC. (1)
4,935,342 Method of isolating and purifying nucleic acids from biological samples 87 1986
 
SYNGENTA LIMITED (1)
5,137,806 Methods and compositions for the detection of sequences in selected DNA molecules 76 1989
 
THE MEDICAL COLLEGE OF PENNSYLVANIA (1)
5,482,834 Evaluation of nucleic acids in a biological sample hybridization in a solution of chaotrophic salt solubilized cells 54 1993
 
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (1)
5,976,800 Enhancement of cancer cell death 13 1997
 
THE ROCKEFELLER UNIVERSITY (1)
5,942,396 Method for identifying individuals at risk for colorectal neoplasia by quantifying normal colonic mucosal epithelial cell apoptosis 10 1997
 
TYCO HEALTHCARE GROUP LP (1)
5,149,506 Stool collection and transport device 81 1991
 
UNIVERSITY OF WASHINGTON (1)
4,358,535 Specific DNA probes in diagnostic microbiology 472 1980
 
V-TECH, INC. (1)
4,735,905 Specimen-gathering apparatus and method 40 1986
 
WAKUNAGA SEIYAKU KABUSHIKI KAISHA (1)
5,688,643 Method of nucleic acid-differentiation and assay kit for nucleic acid differentiation 25 1995
 
WARNER-LAMBERT COMPANY (1)
4,578,358 Collection of specimens and detection of occult blood therein 36 1983
 
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (1)
6,203,993 Methods for the detection of nucleic acids 60 2000
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (7)
4,309,782 Device for collecting fecal specimens 51 1980
4,445,235 Stool specimen collector 38 1982
4,705,050 Moisture-activated floatation device 51 1985
4,982,615 Sterile container for collecting biological samples for purposes of analysis 35 1989
5,331,973 Method for obtaining stool samples for gastrointestinal cancer testing 31 1993
2002/0119,472 Methods for disease diagnosis from stool samples 13 2001
2002/0164,631 Methods for stool sample preparation 14 2002

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
ESOTERIX GENETIC LABORATORIES, LLC (3)
7,776,524 Methods for analysis of molecular events 1 2003
7,811,757 Methods for disease detection 0 2006
8,409,829 Methods for analysis of molecular events 0 2010
 
LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (2)
RE41780 Chemical amplification based on fluid partitioning in an immiscible liquid 0 2008
RE43365 Apparatus for chemical amplification based on fluid partitioning in an immiscible liquid 1 2010

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 6, 2015
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 6, 2019
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00